Keywords: Merck & Co, Rosenthal, Sanofi-Aventis, Weinberg

Top-level appointment at Merck & Co, and Sanofi-Aventis selects chairman

Article | 17 December 2009

Print This

US drug giant Merck & Co, which has recently completed its $41.1 billion acquisition of Schering-Plough, has lured back Michael Rosenblatt ( ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in